INT267959

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.41
First Reported 2009
Last Reported 2010
Negated 0
Speculated 0
Reported most in Body
Documents 2
Total Number 2
Disease Relevance 1.40
Pain Relevance 0

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

extracellular space (APOA1) small molecule metabolic process (APOA1) extracellular region (APOA1)
plasma membrane (APOA1) enzyme binding (APOA1) transmembrane transport (APOA1)
Anatomy Link Frequency
BFA 2
APOA1 (Homo sapiens)
Pain Link Frequency Relevance Heat
Inflammation 8 5.00 Very Low Very Low Very Low
imagery 3 5.00 Very Low Very Low Very Low
Angina 2 5.00 Very Low Very Low Very Low
Bile 1 5.00 Very Low Very Low Very Low
anesthesia 1 5.00 Very Low Very Low Very Low
Tendonitis 1 5.00 Very Low Very Low Very Low
Potency 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Disorder Of Lipid Metabolism 78 100.00 Very High Very High Very High
Hyperlipoproteinemia Type Ii 5 98.32 Very High Very High Very High
Coronary Artery Disease 27 97.68 Very High Very High Very High
Obesity 53 96.44 Very High Very High Very High
Hyperlipidemia 7 79.04 Quite High
Diabetes Mellitus 16 35.08 Quite Low
Increased Venous Pressure Under Development 12 34.28 Quite Low
Metabolic Syndrome 10 15.12 Low Low
Muscle Disease 8 5.00 Very Low Very Low Very Low
INFLAMMATION 8 5.00 Very Low Very Low Very Low

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Rosuvastatin also produced significantly greater reductions in apolipoprotein-B, as well as a significantly greater increase in apolipoprotein A-I.
Negative_regulation (reductions) of Positive_regulation (increase) of apolipoprotein A-I associated with disorder of lipid metabolism
1) Confidence 0.41 Published 2009 Journal Vascular Health and Risk Management Section Body Doc Link PMC2672446 Disease Relevance 1.15 Pain Relevance 0
Indeed, following treatment for 12 hours, BFA inhibits approximately 30% of the basal cholesterol release and 35% of the apoA-I stimulated cholesterol release.
Negative_regulation (inhibits) of Positive_regulation (stimulated) of apoA-I in BFA
2) Confidence 0.34 Published 2010 Journal Lipids Health Dis Section Body Doc Link PMC2917427 Disease Relevance 0.25 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox